TipRanks
Mabpharm Limited (HK:2181)
:2181
Hong Kong Market
2181
Mabpharm Limited
RESEARCH TOOLSreports
Want to see HK:2181 full AI Analyst Report?

Mabpharm Limited (2181) Ratios

0 Followers

Mabpharm Limited Ratios

HK:2181's free cash flow for Q2 2026 was ¥0.86. For the 2026 fiscal year, HK:2181's free cash flow was decreased by ¥ and operating cash flow was ¥0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.83 0.81 1.17 1.08 1.07
Quick Ratio
 0.54 0.56 0.82 0.76 0.53
Cash Ratio
 0.19 0.20 0.29 0.55 0.18
Solvency Ratio
 0.15 0.11 -0.08 -0.18 -0.31
Operating Cash Flow Ratio
 0.20 0.15 -0.01 0.18 -0.30
Short-Term Operating Cash Flow Coverage
 0.76 0.38 -0.05 0.53 0.00
Net Current Asset Value
¥ -558.48M¥ -562.10M¥ -561.51M¥ -487.71M¥ -315.46M
Leverage Ratios
Debt-to-Assets Ratio
 0.26 0.28 0.29 0.25 0.14
Debt-to-Equity Ratio
 1.59 2.08 3.30 1.27 0.32
Debt-to-Capital Ratio
 0.61 0.68 0.77 0.56 0.24
Long-Term Debt-to-Capital Ratio
 0.39 0.30 0.65 0.33 0.17
Financial Leverage Ratio
 6.03 7.33 11.43 5.05 2.29
Debt Service Coverage Ratio
 1.05 0.52 -0.75 -1.18 -21.13
Interest Coverage Ratio
 3.44 0.44 -11.34 -21.09 -31.48
Debt to Market Cap
 0.15 0.15 0.23 0.12 0.05
Interest Debt Per Share
 0.08 0.08 0.07 0.07 0.03
Net Debt to EBITDA
 2.24 3.46 -3.00 -0.62 -0.61
Profitability Margins
Gross Profit Margin
85.42%82.87%84.96%86.32%72.50%
EBIT Margin
4.79%0.74%-46.34%-229.21%-364.16%
EBITDA Margin
12.56%10.00%-26.26%-159.57%-271.97%
Operating Profit Margin
4.79%0.74%-46.34%-231.74%-404.61%
Pretax Profit Margin
4.27%0.64%-49.55%-240.19%-377.01%
Net Profit Margin
11.09%8.84%-49.55%-240.19%-376.66%
Continuous Operations Profit Margin
11.09%8.84%-49.55%-240.19%-377.01%
Net Income Per EBT
259.61%1373.39%100.00%100.00%99.91%
EBT Per EBIT
89.14%86.61%106.91%103.65%93.18%
Return on Assets (ROA)
7.25%4.82%-12.59%-20.23%-22.96%
Return on Equity (ROE)
48.25%35.36%-143.87%-102.10%-52.53%
Return on Capital Employed (ROCE)
5.51%0.76%-17.00%-28.10%-31.03%
Return on Invested Capital (ROIC)
4.45%0.55%-14.93%-23.93%-30.45%
Return on Tangible Assets
8.24%5.26%-13.02%-20.23%-22.96%
Earnings Yield
4.86%3.00%-11.80%-12.18%-13.30%
Efficiency Ratios
Receivables Turnover
 4.97 3.84 2.69 4.49 5.87
Payables Turnover
 2.70 3.57 3.32 1.19 0.93
Inventory Turnover
 0.77 0.79 0.35 0.12 0.15
Fixed Asset Turnover
 1.41 1.11 0.42 0.13 0.08
Asset Turnover
 0.65 0.55 0.25 0.08 0.06
Working Capital Turnover Ratio
 -8.17 -27.28 6.48 4.50 4.39
Cash Conversion Cycle
 413.58 455.38 1.07K 2.90K 2.06K
Days of Sales Outstanding
 73.46 95.07 135.82 81.34 62.22
Days of Inventory Outstanding
 475.11 462.47 1.04K 3.12K 2.39K
Days of Payables Outstanding
 134.99 102.16 110.05 306.50 393.75
Operating Cycle
 548.56 557.54 1.18K 3.21K 2.46K
Cash Flow Ratios
Operating Cash Flow Per Share
 0.02 0.02 >-0.01 0.01 -0.01
Free Cash Flow Per Share
 <0.01 >-0.01 -0.02 <0.01 -0.04
CapEx Per Share
 0.02 0.03 0.01 <0.01 0.03
Free Cash Flow to Operating Cash Flow
 0.18 -0.29 15.52 0.67 3.20
Dividend Paid and CapEx Coverage Ratio
 1.22 0.78 -0.07 3.01 -0.45
Capital Expenditure Coverage Ratio
 1.22 0.78 -0.07 3.01 -0.45
Operating Cash Flow Coverage Ratio
 0.32 0.25 -0.01 0.22 -0.45
Operating Cash Flow to Sales Ratio
 0.13 0.13 -0.02 0.66 -1.02
Free Cash Flow Yield
1.02%-1.25%-5.86%2.23%-11.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 20.62 33.27 -8.48 -8.21 -7.52
Price-to-Sales (P/S) Ratio
 2.28 2.94 4.20 19.72 28.33
Price-to-Book (P/B) Ratio
 8.99 11.77 12.19 8.38 3.95
Price-to-Free Cash Flow (P/FCF) Ratio
 97.83 -79.78 -17.06 44.82 -8.70
Price-to-Operating Cash Flow Ratio
 17.52 22.93 -264.65 29.95 -27.85
Price-to-Earnings Growth (PEG) Ratio
 0.04 -0.23 0.22 13.99 0.27
Price-to-Fair Value
 8.99 11.77 12.19 8.38 3.95
Enterprise Value Multiple
 20.40 32.90 -19.00 -12.98 -11.03
Enterprise Value
 1.96B 2.07B 1.29B 1.81B 1.68B
EV to EBITDA
 20.40 32.90 -19.00 -12.98 -11.03
EV to Sales
 2.56 3.29 4.99 20.72 29.99
EV to Free Cash Flow
 109.87 -89.15 -20.26 47.08 -9.21
EV to Operating Cash Flow
 19.68 25.62 -314.37 31.46 -29.48
Tangible Book Value Per Share
 0.01 0.01 0.01 0.05 0.10
Shareholders’ Equity Per Share
 0.05 0.04 0.02 0.05 0.10
Tax and Other Ratios
Effective Tax Rate
 -1.60 -12.73 0.00 0.00 <0.01
Revenue Per Share
 0.19 0.15 0.06 0.02 0.01
Net Income Per Share
 0.02 0.01 -0.03 -0.05 -0.05
Tax Burden
 2.60 13.73 1.00 1.00 1.00
Interest Burden
 0.89 0.87 1.07 1.05 1.04
Research & Development to Revenue
 0.07 0.08 0.29 1.41 2.65
SG&A to Revenue
 0.74 0.74 0.70 0.24 0.39
Stock-Based Compensation to Revenue
 <0.01 0.02 0.05 0.15 0.17
Income Quality
 3.05 19.42 0.03 -0.27 0.27
Currency in CNY